Processa Pharmaceuticals, Inc. (PCSA) Ownership
PCSA ownership summary
as of October 18, 2026- Institutions
- 18.7% of shares outstanding
- Insiders
- 14.82% of shares outstanding
- Shares outstanding
- 2.8M
- Float
- 2.7M shares available to trade
- Short interest
- 0.17% 4,140 shares short
- Days to cover
- 0.16 short interest down 72.4% vs prior month
- Institutions 18.70%
- Insiders 14.82%
- Other investors 66.48%
PCSA top institutional holders
16 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Connective Capital Management LLC | 3.05% | 85K | $144,113 | +14,538 (+20.6%) | June 30, 2026 |
| 2 | Stonepine Capital Management Llc | 1.97% | 55K | $92,950 | — | June 30, 2026 |
| 3 | Geode Capital Management, LLC | 0.79% | 22K | $37,332 | −2,818 (−11.3%) | June 30, 2026 |
| 4 | Citadel Advisors Llc | 0.76% | 21K | $36,007 | +21,306 (0.0%) | June 30, 2026 |
| 5 | XTX Topco Ltd | 0.48% | 13K | $22,463 | +13,292 (0.0%) | June 30, 2026 |
| 6 | Jane Street Group LLC | 0.47% | 13K | $22,416 | +13,264 (0.0%) | June 30, 2026 |
| 7 | Vanguard Capital Management, LLC | 0.46% | 13K | $21,512 | — | June 30, 2026 |
| 8 | StoneX Group Inc | 0.41% | 11K | $19,329 | +11,437 (0.0%) | June 30, 2026 |
| 9 | Vanguard Fiduciary Trust Co | 0.39% | 11K | $18,348 | — | June 30, 2026 |
| 10 | UBS Group AG | 0.28% | 7,794 | $13,172 | +5,263 (+207.9%) | June 30, 2026 |
| 11 | Tower Research Capital LLC | 0.09% | 2,499 | $4,223 | +1,581 (+172.2%) | June 30, 2026 |
| 12 | JONES FINANCIAL COMPANIES LLLP | <0.01% | 7 | $12 | — | June 30, 2026 |
| 13 | Wells Fargo & Co | 0.00% | — | — | −6 (−100.0%) | June 30, 2026 |
| 14 | Citigroup Inc | 0.00% | — | — | −14 (−100.0%) | June 30, 2026 |
| 15 | Bank of America Corp | 0.00% | — | — | −18 (−100.0%) | March 31, 2026 |
| 16 | HRT FINANCIAL LLC | 0.00% | — | — | −19,691 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 16, 7 holders added 81K shares and 5 cut 23K.
PCSA top mutual fund and ETF holders
3 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.82% | 23K | $38,547 | +8,588 (+60.4%) | August 31, 2026 |
| 2 | Fidelity Series Total Market Index | 0.07% | 2,088 | $3,529 | — | August 31, 2026 |
| 3 | Fidelity Total Market Index | 0.03% | 969 | $1,638 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
PCSA insider transactions
latest 12| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-15 | David Young | Buy | $2.97 | 1,545 | $4,589 |
| 2026-04-15 | George K Ng | Buy | $2.97 | 1,843 | $5,474 |
| 2026-04-15 | Russell Skibsted | Buy | $2.97 | 1,984 | $5,892 |
| 2026-04-15 | Sian Bigora | Buy | $2.97 | 1,799 | $5,343 |
| 2026-04-15 | Wendy Guy | Buy | $2.97 | 1,583 | $4,702 |
| 2026-03-31 | David Young | Buy | $2.54 | 1,810 | $4,597 |
| 2026-03-31 | George K Ng | Buy | $2.54 | 2,136 | $5,425 |
| 2026-03-31 | James R Neal | Buy | $2.54 | 789 | $2,004 |
| 2026-03-31 | Khoso Baluch | Buy | $2.54 | 2,269 | $5,763 |
| 2026-03-31 | Russell Skibsted | Buy | $2.54 | 2,324 | $5,903 |
| 2026-03-31 | Sian Bigora | Buy | $2.54 | 2,107 | $5,352 |
| 2026-03-31 | Wendy Guy | Buy | $2.54 | 1,854 | $4,709 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
PCSA shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns PCSA
Institutional investors own 18.7% of Processa Pharmaceuticals's shares and insiders 14.82%. The largest holder is Connective Capital Management LLC with 3.05% of the shares (85K), as of June 30, 2026. Among the top 16 institutions, 7 added shares and 5 reduced their stake in the latest filings. Short interest is 0.17% of the float, or 0.16 days of average trading volume. The share count rose 1,046.1% since 2014.
Related: PCSA analyst forecast, PCSA key metrics. See the PCSA stock overview for the latest quote and news.
PCSA ownership FAQ
Who owns the most Processa Pharmaceuticals stock?
The largest shareholders of Processa Pharmaceuticals are Connective Capital Management LLC (3.05%), Stonepine Capital Management Llc (1.97%), Geode Capital Management, LLC (0.79%), Citadel Advisors Llc (0.76%), XTX Topco Ltd (0.48%).
What percentage of Processa Pharmaceuticals is owned by institutions?
Institutions hold 18.7% of Processa Pharmaceuticals's shares outstanding; insiders hold 14.82%.
Which funds own Processa Pharmaceuticals?
The largest fund holders of Processa Pharmaceuticals are Fidelity Extended Market Index (0.82%), Fidelity Series Total Market Index (0.07%), Fidelity Total Market Index (0.03%).
What is Processa Pharmaceuticals's short interest?
4,140 shares of Processa Pharmaceuticals were sold short, 0.17% of the float; at the average daily volume it would take 0.16 days to cover.
Are insiders buying or selling Processa Pharmaceuticals?
Of the latest 12 reported insider transactions in Processa Pharmaceuticals (since March 31, 2026), 12 were purchases and 0 were sales.
How many shares of Processa Pharmaceuticals are outstanding?
Processa Pharmaceuticals has 2.8M shares outstanding, of which 2.7M are in the public float.